Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...
The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback